Starting Wegovy at 1.7mg: what the dosing schedule actually says

The misconception: 1.7mg as a shortcut to results

A common belief is that higher doses produce faster results, so starting at a higher step seems logical. It is not. The Wegovy titration schedule is designed around tolerability, not patience. Semaglutide slows gastric emptying and acts on appetite centres in the brain; arriving at a therapeutic dose too quickly floods the body's adjustment window and makes nausea, vomiting and diarrhoea far more likely. The NHS medicines guidance on semaglutide is explicit that the dose is increased gradually to reduce these effects.

The 0.25mg starting dose is often called a tolerability dose precisely because its primary job is letting your system adapt, not driving significant weight loss. If you are considering whether starting at 0.5mg is an option for you, that question is covered in detail separately. By the time a prescriber moves someone to 1.0mg and then 1.7mg, the body has had weeks to adjust, which is exactly why the side-effect profile at those higher doses is manageable for most people. Compressing that process is not a shortcut; it is a common reason treatments get abandoned early. You can read more about how each Wegovy dose step works across the full schedule.

So to be direct: starting at 1.7mg is not a licensed option, not what a responsible prescriber would do, and not what the Wegovy SmPC permits.

What 1.7mg actually is in the schedule, and who reaches it

Under the licensed UK titration pathway, 1.7mg is the fourth of five dose steps. A patient who starts at 0.25mg and moves up on the standard roughly four-weekly schedule reaches 1.7mg at around week twelve, spending one month there before moving (if appropriate) to the 2.4mg maintenance dose at around week sixteen. Not everyone does reach 2.4mg, some people find 1.7mg is their highest tolerated dose, and a prescriber may keep them there. That is a clinical decision, made with information about how the individual is tolerating treatment.

If you are wondering whether you can start Wegovy at 1mg because you have previously been on semaglutide and want to restart, the answer still involves a prescriber's assessment. Restart protocols depend on how long you have been off treatment and what dose you were previously stable on. Restarting at a higher dose is sometimes appropriate, but only a clinician reviewing your history can make that call. Patients transferring to a new provider should bring evidence of their previous dose, which our team asks for at consultation. The detail of whether you can move straight to 2.4mg is answered separately if that is relevant to your situation.

For most people starting Wegovy for the first time, 1.7mg is simply the step you earn by tolerating the earlier ones. Worth knowing before you begin.

Side effects are dose-dependent, this is part of why the schedule exists

Gastrointestinal effects are the most reported issue with semaglutide. Nausea, loose stools, indigestion and fatigue are most common after a dose increase, typically settling within a week or two as the body adjusts. Starting at 1.7mg or higher bypasses four weeks of adaptation at each of the lower steps, so someone who goes in at that level has not given their gut any time to accommodate the drug's effect on gastric emptying.

The NHS semaglutide page lists the most common side effects clearly and notes that taking the dose at the same time each week helps with consistency. A practical detail some people find useful: keeping the pen in the fridge door rather than the back of the shelf makes the weekly routine harder to forget. Beyond nausea, symptoms to take seriously include severe persistent stomach pain, signs of dehydration from repeated vomiting, or any allergic reaction, these warrant prompt medical attention rather than waiting it out.

If you have been considering Wegovy for weight management and are unsure what to expect at each stage, a prescriber can walk through the full picture at consultation, including which dose you would realistically be on at which point.

The route to a Wegovy prescription in the UK

Wegovy is a prescription-only medicine. The only lawful way to obtain it is through a clinical assessment by a registered prescriber who determines suitability, sets the starting dose, and reviews treatment at every stage. NICE recommends semaglutide for weight management under TA875, which also outlines the clinical criteria, BMI thresholds, weight-related conditions, and the requirement for appropriate support alongside treatment.

On the NHS, Wegovy is available through specialist weight management services, though waiting lists can be long. For those who do not meet the current NHS criteria or prefer not to wait, a private regulated pharmacy is an alternative. You can explore what a Wegovy consultation through nume involves (including how a prescriber reviews your case the same day) on the treatments page. Our clinical team reviews every consultation personally, never via automated decision-making.

The cost of private treatment is worth understanding before you begin. A transparent breakdown of what is included versus what some providers leave out is covered on our weight-loss overview. If you are weighing up starting at all rather than which dose to start at, that context is useful. And for those already on treatment wondering about the jump from the current step to the next, our guide to whether starting at 1mg is appropriate covers the specifics in the same way this page does for 1.7mg.

The short version: you cannot start Wegovy at 1.7mg, and any service offering to let you do so without a careful clinical history should raise questions. Speak to our prescribers if you want to understand exactly where in the schedule you would begin.